Early diagnosis of acute renal injury in patients with acute decompensation of chronic heart failure


Early diagnosis of acute kidney injury (AKI) is an urgent problem of providing medical care to patients with acute decompensation of chronic heart failure (ADHF). Aim. To study the possibilities of previously diagnosing acute renal damage in patients with acute decompensation of chronic heart failure with reduced systolic function using biomarkers of acute renal injury. Materials and methods. The study included 60 patients (62.0±11.1 years) with HADS (BNP >500 pg/ml) and a reduced left ventricular ejection fraction (LV 27.05% [23.25; 32.75], c FC III-IV NYHA). The level of creatinine, urea, uric acid, albumin in serum was determined in all patients, as well as a number of biomarkers: lipocalin associated with neutrophil gelatinase (NGAL) and cystatin C (CysC) in serum; kidney damage molecule-1 (KIM-1) and angiotensinogen (AGT) in the urine. Results and discussion. AKI is determined based on changes in serum creatinine concentration or diuresis value. The results obtained indicate a high specificity and sensitivity of the use of biomarkers for the diagnosis of AKI in patients with ADHF. NGAL AUC - 0.833 (p<0.001), Se - 82.8%, Sp - 4.2%. CysC AUC - 0.823 (p<0.001), Se - 79.3%, Sp - 74.2%. KIM-1 AUC - 0.782 (p<0.001), Se - 75.9%, Sp - 74.2%. AGT AUC - 0.829 (p<0.001), Se - 82.8%, Sp - 77.4%. In a multifactorial regression analysis, it was found that with NGAL greater than 157.35 ng/ml, the risk of AKI increases 13.1 times (95% CI 1.365-126.431), with an increase in KIM-1, the risk of the development of AKI increases 20.6 times (95% CI 1.802-235.524), and with an increase in AGT more than 14.31 leng/ml, the risk of AKI increases 32.8 times (95% CI 2.752-390.110). Conclusion. Acute kidney injury develops in 48.3% of patients hospitalized with acute decompensation of chronic heart failure. Patients with acute decompensation of chronic heart failure and AKI have significantly higher serum NGAL and CysC, KIM-1 and AGT values in the urine compared with patients without impairing renal function. These biomarkers can serve both for the early diagnosis of acute kidney damage and the prediction of AKI in patients with acute decompensation of chronic heart failure.

Full Text

Restricted Access

About the authors

S N Nasonova

National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation

Email: dr.nasonova@mail.ru
Moscow, Russia

I V Zhirov

National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation; Russian Medical Academy Continuous Professional Education of the Ministry of Health of the Russian Federation

Moscow, Russia

M V Ledyakhova

National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation

Moscow, Russia

T V Sharf

National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation

Moscow, Russia

E G Bosykh

National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation

Moscow, Russia

V P Masenko

National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation

Moscow, Russia

S N Tereshchenko

National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation; Russian Medical Academy Continuous Professional Education of the Ministry of Health of the Russian Federation

Moscow, Russia


  1. Chioncel O, Mebazaa A, Harjola V.P, Coats A.J, Piepoli M.F, et al. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. ESC Heart Failure Long-Term Registry Investigators. Eur J Heart Fail. 2017;19(10):1242-54. doi: 10.1002/ejhf.890
  2. Logeart D, Isnard R, Resche-Rigon M, Seronde M.F, de Groote P, et al. Heart Failure of the French Society of Cardiology. Current aspects of the spectrum of acute heart failure syndromes in a real - life setting: the OFICA study. Eur J Heart Fail. 2013;15:465-76. doi: 10.1093/eurjhf/hfs189
  3. Panduranga P, Sulaiman K, Al-Zakwani I, Alazzawi A.A, Abraham A, et al. Demographics, Clinical Characteristics, Management, and Outcomes of Acute Heart Failure Patients: Observations from the Oman Acute Heart Failure Registry. Oman Med J. 2016 May;31(3):188-95. doi: 10.5001/omj.2016.37
  4. Harjola V.P, Follath F, Nieminen M.S, Brutsaert D, Dickstein K, et al. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. Eur J Heart Fail. 2010;12:239-48. doi: 10.1093/eurjhf/hfq002
  5. Maggioni A.P, Dahlström U, Filippatos G, Chioncel O, Leiro M.C, et al. Heart Failure Association of ESC (HFA). EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail. 2010 Oct;12(10):1076-84. doi: 10.1093/eurjhf/hfq154
  6. Parenica J, Spinar J, Vitovec J, Widimsky P, Linhart A, et al. Long - term survival following acute heart failure: The Acute Heart Failure Database-Main registry (AHEAD Main). Eur J Intern Med. 2013;24:151-60. doi: 10.1016/j.ejim.2012.11.005
  7. Bader F.M, Attallah N. Insights into cardiorenal interactions in acute decompensated heart failure. Curr Opin Cardiol. 2017 Mar;32(2):203-8. doi: 10.1097/HCO.0000000000000378
  8. Терещенко С.Н., Жиров И.В., Насонова С.Н., Николаева О.А., Ледяхова М.В. Патофизиология острой сердечной недостаточности. Что нового? Российский кардиологический журнал. 2016;9(137):52-64. doi: 10.15829/1560-4071-2016-9-52-64
  9. Жиров И.В., Терещенко С.Н. Место серелаксина в лечении острой сердечной недостаточности: от уменьшения симптоматики к улучшению прогноза. Евразийский кардиологический журнал. 2015;(3):32-7.
  10. Chawla L.S, Amdur R.L, Shaw A.D, Faselis C, Palant C.E, Kimmel P.L. Association between AKI and long - term renal and cardiovascular outcomes in United States veterans. Clin J Am Soc Nephrol. 2014;9:448-56. doi: 10.2215/CJN.02440213
  11. Wu V.C, Wu C.H, Huang T.M, Wang C.Y, Lai C.F, Shiao C.C, et al. Long - term risk of coronary events after AKI. J Am Soc Nephrol. 2014;25:595-605. doi: 10.1681/ASN.2013060610
  12. Odutayo A, Wong C.X, Farkouh M, Altman D.G, Hopewell S, Emdin C.A, et al. AKI and long - term risk for cardiovascular events and mortality. J Am Soc Nephrol. 2017 Jan;28(1):377-87. doi: 10.1681/ASN.2016010105
  13. Piccinni P, Cruz D.N, Gramaticopolo S, Garzotto F, Dal Santo M, Aneloni G, Rocco M, Alessandri E, Giunta F, Michetti V, Iannuzzi M, Belluomo Anello C, Brienza N, Carlini M, Pelaia P, Gabbanelli V, Ronco C. Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT). Minerva Anestesiologica. 2011 Nov;77(11):1072-83.
  14. Mc Cullough P.A, Kellum J.A, Mehta R.L, Murray P.T, Ronco C. ADQI Consensus on AKI Biomarkers and Cardiorenal Syndromes. Contrib Nephrol. Basel, Karger. 2013;182:99-116. doi: 10.1159/000349969
  15. Рекомендации по ведению пациентов с острой сердечной недостаточностью на догоспитальном и госпитальном этапах оказания медицинской помощи (часть 2). Неотложная кардиология. 2017;13(1):34-59.
  16. Prins K, Thenappan T, Markowitz J, Pritzker M. Cardiorenal syndrome type 1: renal dysfunction in acute decompensated heart failure. J Clin Outcomes Manag. 2015;22:443-54.
  17. Jentzer J.C, Chawla L.S. A Clinical Approach to the Acute Cardiorenal Syndrome. Crit Care Clin. 2015 Oct;31(4):685-703. doi: 10.1016/j.ccc.2015.06.006
  18. Shirakabe A, Hata N, Kobayashi N, Okazaki H, Matsushita M, et al. Worsening renal function definition is insufficient for evaluating acute renal failure in acute heart failure. ESC Heart Fail. 2018 Feb 1. doi: 10.1002/ehf2.12264 [Epub ahead of print].
  19. Janssens U, Joannidis M. Acute cardiorenal syndromes. Med Klin Intensivmed Notfmed. 2016 May;111(4):341-58. doi: 10.1007/s00063-016-0159-7. Epub 2016 May 10.
  20. Virzì G.M, Torregrossa R, Cruz D.N, Chionh C.Y, de Cal M, et al. Cardiorenal Syndrome Type 1 May Be Immunologically Mediated: A Pilot Evaluation of Monocyte Apoptosis. Cardiorenal Med. 2012;2(1):33-42. doi: 000335499
  21. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2:1-126.
  22. Shyam R, Patel M.L, Sachan R, Kumar S, Pushkar D.K. Role of Urinary Neutrophil Gelatinase - associated Lipocalin as a Biomarker of Acute Kidney Injury in Patients with Circulatory Shock. Indian J Crit Care Med. 2017 Nov;21(11):740-5. doi: 10.4103/ijccm.IJCCM_315_17
  23. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J. 2012;33:1787-847.
  24. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН (четвертый пересмотр). Сердечная недостаточность. 2013;81(7):379-472.
  25. Клинические Практические Рекомендации KDIGO 2012 по Диагностике и Лечению Хронической Болезни Почек / KGIGO 2012. Нефрология и диализ. 2017;(1):22-206.
  26. Zhou Q, Zhao C, Xie D, Xu D, Bin J, et al. Acute and acute - on - chronic kidney injury of patients with decompensated heart failure: impact on outcomes. BMC Nephrol. 2012;13:51. doi: 10.1186/1471-2369-13-51
  27. Vandenberghe W, Gevaert S, Kellum J.A, Bagshaw S.M, et al. Acute Kidney Injury in Cardiorenal Syndrome Type 1 Patients: A Systematic Review and Meta-Analysis. Cardiorenal Med. 2016;6(2):116-28. doi: 10.1159/000442300
  28. Thind G.S, Loehrke M, Wilt J.L. Acute cardiorenal syndrome: Mechanisms and clinical implications. Cleve Clin J Med. 2018;85(3):231-9. doi: 10.3949/ccjm.85a
  29. Yang C.H, Chang C.H, Chen T.H, Fan P.C, Chang S.W, Chen C.C, et al. Combination of Urinary Biomarkers Improves Early Detection of Acute Kidney Injury in Patients With Heart Failure. Circ J. 2016;80(4):1017-23. doi: 10.1253/circj.CJ-15-0886
  30. Palazzuoli A, Ruocco G, Beltrami M, Franci B, Pellegrini M, et al. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure. Acute Card Care. 2014;16(3):93-101. doi: 10.3109/17482941.2014.911915
  31. Palazzuoli A, Ruocco G, Pellegrini M, De Gori C, et al. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure. Am J Cardiol. 2015;116(1):104-11. doi: 10.1016/j.amjcard.2015.03.043
  32. Nejat M, Pickering J.W, Walker R.J, Endre Z.H. Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol Dial Transplant. 2010;25(10):3283-9. doi: 10.1093/ndt/gfq176
  33. Hu Y, Liu H, Du L, Wan J, Li X. Serum Cystatin C Predicts AKI and the Prognosis of Patients in Coronary Care Unit: a Prospective, Observational Study. Kidney Blood Press Res. 2017;42(6):961-73. doi: 10.1159/000485341
  34. Yang X, Chen C, Tian J, et al. Urinary angiotensinogen level predicts AKI in acute decompensated heart failure: a prospective, two - stage study. J Am Soc Nephrol. 2015;26:2032-41. doi: 10.1681/ASN.2014040408
  35. Chen C, Yang X, Lei Y, Zha Y, Liu H, Ma C, et al. Urinary biomarkers at the time of aki diagnosis as predictors of progression of aki among patients with acute cardiorenal syndrome. Clin J Am Soc Nephrol. 2016;11:1536-44. doi: 10.2215/CJN.00910116



Abstract - 21

PDF (Russian) - 10





  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:


© 2018 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies